peripheral atherosclerosis	is a	vascular disease
visceral atherosclerosis	is a	vascular disease
peripheral atherosclerosis	increases risk of	intermittent claudication
peripheral atherosclerosis	increases risk of	limb ischemia
peripheral atherosclerosis	increases risk of	critical limb ischemia
peripheral atherosclerosis	increases risk of	amputation
visceral atherosclerosis	increases risk of	mesenteric ischemia
visceral atherosclerosis	increases risk of	renal artery stenosis
visceral atherosclerosis	increases risk of	hepatic artery stenosis
peripheral atherosclerosis	associated with	dyslipidemia
peripheral atherosclerosis	associated with	hypertension
peripheral atherosclerosis	associated with	diabetes mellitus
peripheral atherosclerosis	associated with	smoking
visceral atherosclerosis	associated with	dyslipidemia
visceral atherosclerosis	associated with	hypertension
visceral atherosclerosis	associated with	diabetes mellitus
visceral atherosclerosis	associated with	smoking
lipids	associated with	peripheral atherosclerosis
lipids	associated with	visceral atherosclerosis
inflammation	associated with	peripheral atherosclerosis
inflammation	associated with	visceral atherosclerosis
oxidative stress	associated with	peripheral atherosclerosis
oxidative stress	associated with	visceral atherosclerosis
age	increases risk of	peripheral atherosclerosis
age	increases risk of	visceral atherosclerosis
obesity	associated with	peripheral atherosclerosis
obesity	associated with	visceral atherosclerosis
physical inactivity	associated with	peripheral atherosclerosis
physical inactivity	associated with	visceral atherosclerosis
smoking	increases risk of	peripheral atherosclerosis
smoking	increases risk of	visceral atherosclerosis
hypertension	contributes to	peripheral atherosclerosis
hypertension	contributes to	visceral atherosclerosis
diabetes mellitus	contributes to	peripheral atherosclerosis
diabetes mellitus	contributes to	visceral atherosclerosis
dyslipidemia	contributes to	peripheral atherosclerosis
dyslipidemia	contributes to	visceral atherosclerosis
statins	reduce risk of progression	peripheral atherosclerosis
statins	reduce risk of progression	visceral atherosclerosis
antiplatelet therapy	reduces events in	peripheral atherosclerosis
antiplatelet therapy	reduces events in	visceral atherosclerosis
endovascular therapy	treats	peripheral atherosclerosis
endovascular therapy	treats	visceral atherosclerosis
bypass surgery	treats	peripheral atherosclerosis
bypass surgery	treats	visceral atherosclerosis
lifestyle modification	slows progression of	peripheral atherosclerosis
lifestyle modification	slows progression of	visceral atherosclerosis
angiography	identifies	luminal stenosis
renal artery stenosis	coexists with	visceral atherosclerosis
renal artery stenosis	associated with	hypertension
renal artery stenosis	associated with	atherosclerosis
mesenteric ischemia	caused by	visceral atherosclerosis
myocardial infarction	associated with	atherosclerosis
stroke	associated with	atherosclerosis
mortality	associated with	peripheral atherosclerosis
mortality	associated with	visceral atherosclerosis
readmission	associated with	peripheral atherosclerosis
readmission	associated with	visceral atherosclerosis
polyvascular disease	coexists with	peripheral atherosclerosis
polyvascular disease	coexists with	visceral atherosclerosis
systemic atherosclerosis	includes	peripheral atherosclerosis
systemic atherosclerosis	includes	visceral atherosclerosis
carotid atherosclerosis	coexists with	peripheral atherosclerosis
carotid atherosclerosis	coexists with	visceral atherosclerosis
aortic atherosclerosis	coexists with	peripheral atherosclerosis
aortic atherosclerosis	coexists with	visceral atherosclerosis
endothelial dysfunction	associated with	peripheral atherosclerosis
endothelial dysfunction	associated with	visceral atherosclerosis
nephropathy	associated with	visceral atherosclerosis
nephropathy	associated with	peripheral atherosclerosis
renal failure	worsened by	visceral atherosclerosis
renal failure	worsened by	peripheral atherosclerosis
ischemic pain	due to	peripheral atherosclerosis
ischemic pain	due to	visceral atherosclerosis
graft patency	affected by	visceral atherosclerosis
graft patency	affected by	peripheral atherosclerosis
stent patency	affected by	peripheral atherosclerosis
stent patency	affected by	visceral atherosclerosis
angioplasty outcome	influenced by	peripheral atherosclerosis
angioplasty outcome	influenced by	visceral atherosclerosis
hemodynamics	altered by	peripheral atherosclerosis
hemodynamics	altered by	visceral atherosclerosis
blood pressure	controlled by	antihypertensive therapy
blood pressure	targeted by	antihypertensive therapy
glycemic control	improves	peripheral atherosclerosis outcomes
glycemic control	improves	visceral atherosclerosis outcomes
proteinuria	associated with	peripheral atherosclerosis
proteinuria	associated with	visceral atherosclerosis
lipoprotein(a)	associated with	peripheral atherosclerosis
lipoprotein(a)	associated with	visceral atherosclerosis
LDL cholesterol	associated with	peripheral atherosclerosis
LDL cholesterol	associated with	visceral atherosclerosis
statin therapy	reduces	LDL cholesterol
statin therapy	reduces	triglycerides
antiplatelet therapy	reduces	cardiovascular events
revascularization	indicated for	peripheral atherosclerosis
revascularization	indicated for	visceral atherosclerosis
risk stratification	guides	management of peripheral atherosclerosis
risk stratification	guides	management of visceral atherosclerosis
monitoring	informs	prognosis of visceral atherosclerosis
